PUBLISHED ON APR 01, 2021 04:59 PM IST
In the US alone, the efficacy rate was 92.6%, according to a report Thursday by Pfizer and its partner BioNTech SE.
PUBLISHED ON APR 01, 2021 02:49 AM IST
The vaccine maker and its partner BioNTech will submit the data to regulators in the US and Europe.
UPDATED ON MAR 30, 2021 05:47 PM IST
Pfizer and BioNTech had previously spoken of being able to make 2 billion doses in 2021.
PUBLISHED ON MAR 30, 2021 07:54 AM IST
States opening eligibility to anyone ages 16 and older on Monday included Texas, Oklahoma, Louisiana, Ohio, North Dakota and Kansas.
UPDATED ON MAR 09, 2021 08:23 AM IST
Pfizer has said it believes its current Covid-19 vaccine is highly likely to still protect against the South African variant but is planning to test a third booster dose of it as well as a version retooled specifically to combat the variant in order to better understand the immune response
PUBLISHED ON FEB 22, 2021 08:28 PM IST
Results of the study covering the entire Scottish population of 5.4 million showed that by the fourth week after the initial dose, the Pfizer and AstraZeneca vaccines cut the risk of hospitalisation by up to 85% and 94% respectively.
PUBLISHED ON FEB 20, 2021 06:36 AM IST
The drugmaker's chief executive used a visit by the US president to announce that he expects to double the doses per week the company currently provides to the US government.
PUBLISHED ON FEB 18, 2021 08:29 PM IST
Researchers at Pfizer and the University of Texas Medical Branch for the study of genetically engineered versions of the virus to carry some of the mutations found in B1351 variant.
PUBLISHED ON JAN 23, 2021 09:18 PM IST
AstraZeneca has said it believes a first dose of its vaccine offers protection after 12 weeks, but Pfizer says it has not tested the efficacy of its jab after such a long gap.
PUBLISHED ON JAN 16, 2021 07:36 PM IST
Common reactions to the vaccine, including fever and nausea, "may have contributed to a fatal outcome in some frail patients," said Sigurd Hortemo of the Norwegian Medicines Agency.
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Srivatsan K C
UPDATED ON JAN 08, 2021 04:58 PM IST
“With the new agreement, we could purchase a total of up to an additional 300 million doses of the vaccine. In other words, this will allow us to double the number of doses,” President of the European Commission Ursula von der Leyen said.
Singapore | By Reuters | Posted by Srivatsan K C
PUBLISHED ON JAN 08, 2021 12:33 PM IST
Unlike other mass vaccination programmes in the United States and Britain, Singapore is administering the jabs having largely eradicated the disease and has reported only a handful of local cases in recent months.
By Bloomberg | Posted by Srivatsan K C
PUBLISHED ON DEC 27, 2020 05:55 PM IST
The country’s health service would no longer be at risk of being overwhelmed by Covid-19 cases once the threshold of 15 million vulnerable people are vaccinated, the newspaper said.
Rome | By Reuters | Posted by Srivatsan K C
PUBLISHED ON DEC 27, 2020 02:50 PM IST
Three health workers at the Rome Spallanzani hospital were inoculated shortly before 0700 GMT with the vaccine developed by Pfizer and BioNTech, a statement by the commissioner for the epidemic Domenico Arcuri said.
By Reuters | Posted by Srivatsan K C
UPDATED ON DEC 26, 2020 11:07 PM IST
The region of 450 million people has secured contracts with a range of suppliers for over two billion vaccine doses and has set a goal for all adults to be inoculated during 2021.